1. Home
  2. XAIR vs PCLA Comparison

XAIR vs PCLA Comparison

Compare XAIR & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XAIR
  • PCLA
  • Stock Information
  • Founded
  • XAIR 2011
  • PCLA 2008
  • Country
  • XAIR United States
  • PCLA Japan
  • Employees
  • XAIR N/A
  • PCLA N/A
  • Industry
  • XAIR Medical/Dental Instruments
  • PCLA Building Products
  • Sector
  • XAIR Health Care
  • PCLA Consumer Discretionary
  • Exchange
  • XAIR Nasdaq
  • PCLA Nasdaq
  • Market Cap
  • XAIR 17.0M
  • PCLA 18.6M
  • IPO Year
  • XAIR N/A
  • PCLA 2025
  • Fundamental
  • Price
  • XAIR $2.40
  • PCLA $0.50
  • Analyst Decision
  • XAIR Strong Buy
  • PCLA
  • Analyst Count
  • XAIR 1
  • PCLA 0
  • Target Price
  • XAIR $11.00
  • PCLA N/A
  • AVG Volume (30 Days)
  • XAIR 8.8M
  • PCLA 203.4K
  • Earning Date
  • XAIR 11-10-2025
  • PCLA 01-01-0001
  • Dividend Yield
  • XAIR N/A
  • PCLA N/A
  • EPS Growth
  • XAIR N/A
  • PCLA N/A
  • EPS
  • XAIR N/A
  • PCLA N/A
  • Revenue
  • XAIR $4,782,000.00
  • PCLA $5,475,228.00
  • Revenue This Year
  • XAIR $265.24
  • PCLA N/A
  • Revenue Next Year
  • XAIR $136.17
  • PCLA N/A
  • P/E Ratio
  • XAIR N/A
  • PCLA N/A
  • Revenue Growth
  • XAIR 168.20
  • PCLA 40.19
  • 52 Week Low
  • XAIR $2.02
  • PCLA $0.37
  • 52 Week High
  • XAIR $13.52
  • PCLA $9.80
  • Technical
  • Relative Strength Index (RSI)
  • XAIR 48.22
  • PCLA 46.73
  • Support Level
  • XAIR $2.13
  • PCLA $0.42
  • Resistance Level
  • XAIR $4.78
  • PCLA $0.55
  • Average True Range (ATR)
  • XAIR 0.33
  • PCLA 0.04
  • MACD
  • XAIR 0.05
  • PCLA 0.03
  • Stochastic Oscillator
  • XAIR 11.63
  • PCLA 64.80

About XAIR Beyond Air Inc.

Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

Share on Social Networks: